发明名称 uso de um composto da fórmula (i),(ii),(iii), ou (iv) ou um sal farmaceuticamente aceitável seu para a fabricação de um medicamento para o tratamento de câncer em um humano ou um animal; método para o tratamento de câncer, pacote comercial, método para redução de células cancerosas e kit para o tratamento de câncer
摘要 This invention provides a medicament for the treatment of cancer, which cause a reduction of cancer. This invention relates to use of a compound which has inhibitory activities against prostaglandin E2 receptor (EP4 receptor) and is represented by the following general formula (I), (II), (III), or (IV), or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt for the manufacture of a medicament for the treatment of cancer. The invention relates to a method for treatment of cancer comprising administering the compound or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or the salt to humans or animals. The compound or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition may be used in combination with one or more second active agents.
申请公布号 BRPI1014174(A2) 申请公布日期 2016.04.05
申请号 BR2010PI14174 申请日期 2010.04.22
申请人 RAQUALIA PHARMA INC. 发明人 KAZUHIKO NONOMURA;SHINICHI KOIZUMI;TAKAKO OKUMURA;YUKINORI TAKE
分类号 C07D213/64;A61K31/192;A61K31/437;A61K31/4412;A61P35/00;A61P43/00;C07D471/04 主分类号 C07D213/64
代理机构 代理人
主权项
地址